SETD5
Basic information
Region (hg38): 3:9397615-9479240
Links
Phenotypes
GenCC
Source:
- intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency (Definitive), mode of inheritance: AD
- intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency (Supportive), mode of inheritance: AD
- intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency (Strong), mode of inheritance: AD
- syndromic complex neurodevelopmental disorder (Definitive), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Intellectual developmental disorder, autosomal dominant 23 | AD | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Craniofacial; Musculoskeletal; Neurologic | 24680889 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (85 variants)
- Intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency (42 variants)
- Inborn genetic diseases (8 variants)
- SETD5-related disorder (3 variants)
- See cases (3 variants)
- Developmental disorder (2 variants)
- Neurodevelopmental disorder (2 variants)
- Intellectual disability (1 variants)
- Cornelia de Lange-like syndrome (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SETD5 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 129 | 18 | 152 | |||
missense | 11 | 354 | 73 | 448 | ||
nonsense | 40 | 12 | 53 | |||
start loss | 0 | |||||
frameshift | 70 | 20 | 94 | |||
inframe indel | 8 | |||||
splice donor/acceptor (+/-2bp) | 17 | |||||
splice region | 2 | 1 | 19 | 21 | 43 | |
non coding | 63 | 33 | 103 | |||
Total | 120 | 51 | 380 | 266 | 58 |
Variants in SETD5
This is a list of pathogenic ClinVar variants found in the SETD5 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
3-9424472-C-T | Uncertain significance (Jan 08, 2024) | |||
3-9428935-C-T | Uncertain significance (Jan 10, 2022) | |||
3-9428937-T-C | Uncertain significance (Dec 19, 2022) | |||
3-9428945-A-G | Uncertain significance (Dec 21, 2023) | |||
3-9428946-T-C | Uncertain significance (Feb 08, 2023) | |||
3-9428948-G-T | Uncertain significance (Jun 06, 2023) | |||
3-9428951-A-G | Inborn genetic diseases | Conflicting classifications of pathogenicity (Dec 27, 2023) | ||
3-9428952-T-A | Likely benign (Sep 14, 2022) | |||
3-9428957-C-G | SETD5-related disorder | Uncertain significance (Jun 09, 2023) | ||
3-9428963-G-T | Intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency | Uncertain significance (May 21, 2020) | ||
3-9428969-A-G | Uncertain significance (Jan 25, 2024) | |||
3-9428973-C-T | Uncertain significance (Dec 06, 2023) | |||
3-9428989-A-G | not specified | Uncertain significance (May 04, 2022) | ||
3-9429005-T-G | Uncertain significance (Feb 04, 2022) | |||
3-9429012-A-G | See cases | Uncertain significance (Sep 14, 2021) | ||
3-9429028-G-A | Likely benign (Oct 13, 2023) | |||
3-9433832-C-T | Likely benign (Jul 20, 2023) | |||
3-9433833-G-A | Likely benign (May 05, 2023) | |||
3-9433836-T-C | Likely benign (Apr 06, 2023) | |||
3-9433846-C-G | Intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency | Uncertain significance (Feb 14, 2019) | ||
3-9433852-T-A | Uncertain significance (Nov 19, 2023) | |||
3-9433855-G-C | Uncertain significance (Feb 16, 2024) | |||
3-9433860-G-A | Likely benign (May 01, 2022) | |||
3-9433886-G-A | Uncertain significance (Jul 13, 2022) | |||
3-9433889-T-G | SETD5-related syndromic intellectual disability | Uncertain significance (Dec 16, 2020) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SETD5 | protein_coding | protein_coding | ENST00000402198 | 21 | 81626 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.00 | 0.0000298 | 124610 | 0 | 32 | 124642 | 0.000128 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.13 | 683 | 772 | 0.885 | 0.0000430 | 9258 |
Missense in Polyphen | 177 | 311.9 | 0.56748 | 3567 | ||
Synonymous | -0.684 | 296 | 281 | 1.05 | 0.0000144 | 2959 |
Loss of Function | 6.70 | 9 | 69.1 | 0.130 | 0.00000434 | 803 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00106 | 0.00106 |
Ashkenazi Jewish | 0.000201 | 0.000199 |
East Asian | 0.000111 | 0.000111 |
Finnish | 0.0000464 | 0.0000464 |
European (Non-Finnish) | 0.0000355 | 0.0000354 |
Middle Eastern | 0.000111 | 0.000111 |
South Asian | 0.000132 | 0.000131 |
Other | 0.000333 | 0.000330 |
dbNSFP
Source:
- Function
- FUNCTION: Probable transcriptional regulator that acts via the formation of large multiprotein complexes that modify and/or remodel the chromatin. Acts as a regulator of histone acetylation during gene transcription. {ECO:0000250|UniProtKB:Q5XJV7}.;
- Disease
- DISEASE: Mental retardation, autosomal dominant 23 (MRD23) [MIM:615761]: A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. MRD23 patients manifest moderate to severe intellectual disability with additional variable features of brachycephaly, a low hairline, depressed nasal bridge, prominent high nasal root, tubular nose, upslanting palpebral fissures, long and smooth philtrum, micrognathia, thin upper lip, and crowded teeth. Behavioral problems, including obsessive-compulsive disorder, hand flapping with ritualized behavior, and autism, are prominent features. {ECO:0000269|PubMed:24680889, ECO:0000269|PubMed:25138099, ECO:0000269|PubMed:27375234, ECO:0000269|PubMed:28549204}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Histone Modifications
(Consensus)
Recessive Scores
- pRec
- 0.107
Intolerance Scores
- loftool
- 0.0174
- rvis_EVS
- -0.79
- rvis_percentile_EVS
- 12.6
Haploinsufficiency Scores
- pHI
- 0.467
- hipred
- N
- hipred_score
- 0.481
- ghis
- 0.653
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.797
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Setd5
- Phenotype
- growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); endocrine/exocrine gland phenotype; muscle phenotype; craniofacial phenotype; homeostasis/metabolism phenotype; skeleton phenotype; renal/urinary system phenotype; embryo phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); pigmentation phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); vision/eye phenotype; immune system phenotype;
Zebrafish Information Network
- Gene name
- setd5
- Affected structure
- head
- Phenotype tag
- abnormal
- Phenotype quality
- decreased size
Gene ontology
- Biological process
- covalent chromatin modification;regulation of histone acetylation;regulation of chromatin organization
- Cellular component
- nucleus;nucleoplasm;Cdc73/Paf1 complex
- Molecular function